Span Divergent cash drops to Rs 84.36 lakh in September

Span Divergent Limited ended September 30, 2026 with consolidated cash and cash equivalents of Rs 84.36 lakh, down from Rs 6.4768 crore at March 31, 2026, after a Rs 7.2666 crore operating cash outflow in the six months, driven principally by Rs 3.5827 crore inventory and Rs 1.2178 crore receivables increases.

Why did Span Divergent's cash balance fall?

Span Divergent's cash balance fell because operating and investing cash outflows exceeded financing inflows in the six months ended September 30, 2026. Operating activities used Rs 7.2666 crore and investing activities used Rs 1.5934 crore, while financing activities generated Rs 3.2268 crore. The resulting net decline was Rs 5.6332 crore from the Rs 6.4768 crore opening cash balance.

The group reported a pre-tax loss of Rs 1.908 crore for the half year, compared with a Rs 30.94 lakh pre-tax loss in the corresponding six months of 2025. After depreciation, finance costs, investment gains and working-capital movements, cash generated from operations was negative Rs 7.357 crore. The cash-flow statement then reported Rs 9.04 lakh of income taxes paid, producing net operating cash outflow of Rs 7.2666 crore.

The six-month operating outflow is not directly comparable with the full-year operating inflow of Rs 21.63 lakh for the year ended March 31, 2026 because the reporting periods differ. Still, the balance sheet and cash-flow statement both show that cash fell sharply by September 30, while total current assets increased modestly to Rs 19.2752 crore from Rs 19.1158 crore at March 31.

How did inventory and receivables absorb Span Divergent's cash?

Inventory and trade receivables were the largest disclosed uses of operating cash at Span Divergent during the half year. Current inventory increased by Rs 3.5827 crore and current trade receivables increased by Rs 1.2178 crore, together absorbing Rs 4.8005 crore. Other current assets increased by Rs 98.74 lakh and current other financial assets increased by Rs 31.34 lakh.

Inventory stood at Rs 5.306 crore on September 30, 2026, compared with Rs 1.7233 crore at March 31, 2026. Trade receivables rose to Rs 2.758 crore from Rs 1.5402 crore over the same period. Current investments declined by Rs 24.49 lakh to Rs 4.9094 crore, while cash fell by Rs 5.6332 crore, limiting the increase in total current assets.

The inventory movement followed a March 28, 2026 preferential issue that raised Rs 5.7936 crore. Span Divergent allocated Rs 5 crore to procurement of raw cashew nut inventory described as two to three months of upfront inventory, Rs 50 lakh to restart and ramp-up costs, and Rs 29.36 lakh to selective refurbishment for productivity and quality. The company said the proceeds assigned to the specified objects had been fully utilised by the September 2026 quarter, with no deviation or variation reported.

How did Span Divergent fund the cash outflow?

Span Divergent funded part of the outflow through additional current borrowings, which rose by Rs 3.5257 crore to Rs 10.4524 crore at September 30, 2026 from Rs 6.9267 crore at March 31. The consolidated cash-flow statement reported Rs 3.5257 crore of proceeds from borrowings, matching the movement in current borrowings.

Financing cash inflow was Rs 3.2268 crore after Rs 29.89 lakh of interest paid. Total liabilities increased to Rs 22.8655 crore from Rs 19.0753 crore, while total equity declined to Rs 7.9004 crore from Rs 9.8271 crore. Other equity fell to Rs 5.911 crore from Rs 7.5961 crore, and non-controlling interest was negative Rs 5.2738 crore at September 30.

Lease obligations also increased during the period. Non-current lease liabilities rose to Rs 93.18 lakh from Rs 9.13 lakh, while current lease liabilities increased to Rs 29.94 lakh from Rs 11.89 lakh. Trade payables to creditors other than micro and small enterprises declined to Rs 5.2694 crore from Rs 5.6884 crore, whereas other financial liabilities rose to Rs 2.2838 crore from Rs 1.9272 crore.

What did Span Divergent's operating segments report?

Span Divergent reported net segment revenue of Rs 6.9189 crore for the six months ended September 30, 2026, down from Rs 8.8858 crore in the corresponding period a year earlier. Cashew processing generated Rs 5.7158 crore, compared with Rs 6.7298 crore a year earlier, while trading revenue fell to Rs 1.2031 crore from Rs 2.156 crore. Tissue Culture reported no half-year revenue.

Cashew processing recorded a loss before interest and tax of Rs 1.0003 crore, versus a Rs 89.18 lakh loss in the prior-year half. Trading recorded a Rs 48.45 lakh loss, compared with a Rs 7.01 lakh profit in the corresponding period. Tissue Culture reported a Rs 21,000 loss, while unallocable income over expenses changed to a Rs 2.11 lakh loss from a Rs 75.25 lakh positive contribution.

In the September 2026 quarter, cashew-processing revenue was Rs 5.3617 crore, higher than Rs 3.7956 crore in the preceding June quarter but below Rs 6.577 crore in the September 2025 quarter. Cashew-processing segment assets increased to Rs 17.9963 crore at September 30 from Rs 9.2685 crore at March 31, while segment liabilities increased to Rs 6.913 crore from Rs 3.3651 crore.

What unresolved subsidiary matters did Span Divergent disclose?

Span Divergent said Aranya Consulting and Biotech LLP had accumulated losses of Rs 14.95 crore through March 31, 2026 and incurred a Rs 1.37 lakh loss in the current year through September 30. Its board approved a plan to revive the limited liability partnership from its non-operational state in light of potential new opportunities, and the LLP's assets were reclassified as property, plant and equipment.

Biospan Contamination Control Solution Pvt. Ltd had accumulated losses of Rs 7.69 crore through September 30, 2026, and its total liabilities exceeded total assets by Rs 7.59 crore. Management said it believed the losses were temporary and that appropriate product introductions could establish adequate revenue and turn negative net worth positive in a short-term horizon.

Biospan Scientific LLP had accumulated losses of Rs 1.57 crore as of March 31, 2019, according to the filing. Management said it was exploring revival of the LLP either independently or through business tie-ups. The consolidated results for the September 2026 quarter and half year were approved by the board on November 5, 2026, following audit committee review.

Conclusion

Span Divergent's September 2026 consolidated figures show cash falling to Rs 84.36 lakh as Rs 7.2666 crore of operating outflow and Rs 1.5934 crore of investing outflow outweighed Rs 3.2268 crore of financing inflow. The largest identified operating cash uses were the Rs 3.5827 crore inventory increase and Rs 1.2178 crore receivables increase, while current borrowings rose by Rs 3.5257 crore.

The next reporting periods will show whether the Rs 5 crore raw-cashew inventory allocation supports cashew-processing revenue and cash conversion. Investors can also watch progress on the board-approved revival of Aranya Consulting and Biotech LLP, and management's stated product-introduction plan for Biospan Contamination Control Solution Pvt. Ltd to address its negative net worth.